Status:
UNKNOWN
Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients
Lead Sponsor:
Cairo University
Conditions:
Preeclampsia
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Admission CTG for 20 minutes Settings on a CTG machine was standardised to enable a consistent approach of interpretation of traces. Paper speed of 3cm per minute will be adopted. Maternal heart rate ...
Detailed Description
Admission CTG: Admission CTG will be performed for 20 minutes I-Settings: 1. Settings on a CTG machine will be standardised to enable a consistent approach of interpretation of traces. 2. Paper spe...
Eligibility Criteria
Inclusion
- Pregnant Women in the third trimester.
- Severely preeclamptic patients.
- Singleton Pregnancy.
- Patients with normal admission CTG
Exclusion
- Evidence of fetal anomalies on scan.
- Concomitant maternal morbidities as diabetes, cardiac disease.
- Patients contraindicated to take MgSo4 e.g.: advanced renal disease.
- Abnormal admission CTG.
- Morbid obesity.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03237000
Start Date
August 1 2017
End Date
January 1 2018
Last Update
August 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy medical school
Cairo, Egypt, 12151